568 related articles for article (PubMed ID: 28631886)
1. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
2. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
[TBL] [Abstract][Full Text] [Related]
3. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
[TBL] [Abstract][Full Text] [Related]
5. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.
Chen K; Zhang J; Zhang W; Zhang J; Yang J; Li K; He Y
Int J Biochem Cell Biol; 2013 May; 45(5):932-43. PubMed ID: 23434541
[TBL] [Abstract][Full Text] [Related]
6. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.
Qiu YY; Tang LQ
Pharmacol Res; 2016 Dec; 114():251-264. PubMed ID: 27826011
[TBL] [Abstract][Full Text] [Related]
7. Correlation Between Plasma NLRP3, IL-1β, and IL-18 and Diabetic Nephropathy in Patients With Type 2 Diabetes.
Yuan Y; Li L; Wang X; Zhang P; Wang J; Xiao Y
Altern Ther Health Med; 2023 May; 29(4):52-56. PubMed ID: 36947659
[TBL] [Abstract][Full Text] [Related]
8. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
[TBL] [Abstract][Full Text] [Related]
9. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy.
Al-Kafaji G; Al-Muhtaresh HA
Mol Med Rep; 2018 Jul; 18(1):1171-1180. PubMed ID: 29845236
[TBL] [Abstract][Full Text] [Related]
10. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in
Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
[TBL] [Abstract][Full Text] [Related]
12. Role of the thioredoxin interacting protein in diabetic nephropathy and the mechanism of regulating NOD‑like receptor protein 3 inflammatory corpuscle.
Gu C; Liu S; Wang H; Dou H
Int J Mol Med; 2019 Jun; 43(6):2440-2450. PubMed ID: 31017263
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
[TBL] [Abstract][Full Text] [Related]
14. Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome.
Samra YA; Said HS; Elsherbiny NM; Liou GI; El-Shishtawy MM; Eissa LA
Life Sci; 2016 Jul; 157():187-199. PubMed ID: 27266851
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
16. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV ameliorates diabetic nephropathy in
Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
[TBL] [Abstract][Full Text] [Related]
18. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
19. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Zhu Y; Zhu C; Yang H; Deng J; Fan D
Pharmacol Res; 2020 May; 155():104746. PubMed ID: 32156650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]